Precision IFX: Using a Dashboard to Individualize Infliximab Dosage

NCT02624037 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
189
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators